Evidence map›Paper›PMID 27690086›Full record

ReviewViruses2016

Multi-Omics Studies towards Novel Modulators of Influenza A Virus-Host Interaction.

Sandra Söderholm, Yu Fu, Lana Gaelings, Sergey Belanov, Laxman Yetukuri, Mikhail Berlinkov, Anton V Cheltsov, Simon Anders, Tero Aittokallio, Tuula A Nyman and 2 more

Abstract readReview
In one paragraph

Review in Viruses, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sandra SöderholmInstitute of Biotechnology, University of Helsinki, Helsinki 00014, Finland. sandra.soderholm@helsinki.fi.
Yu FuInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00014, Finland. yu.fu@helsinki.fi.
Lana GaelingsInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00014, Finland. lgaelings@stud.hs-bremen.de.
Sergey BelanovInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00014, Finland. sergei.belanov@helsinki.fi.
Laxman YetukuriInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00014, Finland. yetulax@mappi.helsinki.fi.
Mikhail BerlinkovInstitute of Mathematics and Computer Science, Ural Federal University, Yekaterinburg 620083, Russia. berlm@mail.ru.
Anton V CheltsovQ-Mol L.L.C. in Silico Pharmaceuticals, San Diego, CA 92037, USA. anton.cheltsov@gmail.com.
Simon AndersInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00014, Finland. simon.anders@fimm.fi.
Tero AittokallioInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00014, Finland. tero.aittokallio@fimm.fi.
Tuula A NymanInstitute of Clinical Medicine, Oslo 0450, Norway. t.a.nyman@medisin.uio.no.
Sampsa MatikainenFinnish Institute of Occupational Health, Helsinki 00250, Finland. sampsa.matikainen@helsinki.fi.
Denis E KainovInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00014, Finland. denis.kainov@helsinki.fi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human influenza A viruses (IAVs) cause global pandemics and epidemics. These viruses evolve rapidly, making current treatment options ineffective. To identify novel modulators of IAV-host interactions, we re-analyzed our recent transcriptomics, metabolomics, proteomics, phosphoproteomics, and genomics/virtual ligand screening data. We identified 713 potential modulators targeting 199 cellular and two viral proteins. Anti-influenza activity for 48 of them has been reported previously, whereas the antiviral efficacy of the 665 remains unknown. Studying anti-influenza efficacy and immuno/neuro-modulating properties of these compounds and their combinations as well as potential viral and host resistance to them may lead to the discovery of novel modulators of IAV-host interactions, which might be more effective than the currently available anti-influenza therapeutics.

Indexed as

antiviral agentgenomicsinfluenza virusmetabolomicsphosphoproteomicsproteomicstranscriptomicsvirtual ligand screening

Identifiers

PMID27690086
PMCPMC5086605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.